Interferon-γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) β2

Journal of Cellular Physiology

Volumn 228, Issue 8, 2013, Pages 1774-1783

  Chrobak, Izabela ^a   Lenna, Stefania ^a   Stawski, Lukasz ^a   Trojanowska, Maria ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BOSENTAN; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN 1; GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; ENZYME INDUCTION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MICROVASCULAR ENDOTHELIAL CELL; PATHOGENESIS; PREPUCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; VASCULAR REMODELING;

CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FIBROSIS; HUMANS; INTERFERON-GAMMA; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTOR BETA2; UP-REGULATION;

EID: 84876697769     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24337     Document Type: Article

References (46)

1. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Manfredi A, Frascerra S, Franzoni F, Galetta F, Ferrannini E. 2008. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis-A longitudinal study. Rheumatology (Oxford) 47:45-49.
2. Antonelli A, Ferri C, Ferrari SM, Mancusi C, Colaci M, Sebastiani M, Fallahi P. 2011. IFN-gamma and TNF-alpha induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. Scand J Rheumatol 40:453-456.
3. Asano Y, Stawski L, Hant F, Highland K, Silver R, Szalai G, Watson DK, Trojanowska M. 2010. Endothelial Fli1 deficiency impairs vascular homeostasis: A role in scleroderma vasculopathy. Am J Pathol 176:1983-1998.
4. Bellisai F, Morozzi G, Scaccia F, Chellini F, Simpatico A, Pecetti G, Galeazzi M. 2011. Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis. Int J Immunopathol Pharmacol 24:261-264.
5. Billiau A, Matthys P. 2009. Interferon-gamma: A historical perspective. Cytokine Growth Factor Rev 20:97-113.
6. Capaldo CT, Nusrat A. 2009. Cytokine regulation of tight junctions. Biochim Biophys Acta 1788:864-871.
7. Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. 2004. T lymphocyte-endothelial cell interactions. Annu Rev Immunol 22:683-709.
8. Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK, Adams LD, Furst DE, Schwartz SM. 2008. Capillary regeneration in scleroderma: Stem cell therapy reverses phenotype? PLoS ONE 3:e1452.
9. Fleming JN, Nash RA, Mahoney WM, Jr., Schwartz SM. 2009. Is scleroderma a vasculopathy? Curr Rheumatol Rep 11:103-110.
10. Gillery P, Serpier H, Polette M, Bellon G, Clavel C, Wegrowski Y, Birembaut P, Kalis B, Cariou R, Maquart FX. 1992. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts. Eur J Cell Biol 57:244-253.
11. Giordano N, Puccetti L, Papakostas P, Di Pietra N, Bruni F, Pasqui AL, Acampa M, Bocchi V, Donati V, Voglino M, Fioravanti A, Montella A, Auteri A, Nuti R, Pastorelli M. 2010. Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: An open-label, observational, retrospective study. Int J Immunopathol Pharmacol 23:1185-1194.
12. Grassegger A, Schuler G, Hessenberger G, Walder-Hantich B, Jabkowski J, MacHeiner W, Salmhofer W, Zahel B, Pinter G, Herold M, Klein G, Fritsch PO. 1998. Interferon-gamma in the treatment of systemic sclerosis: A randomized controlled multicentre trial. Br J Dermatol 139:639-648.
13. Hachulla E, Denton CP. 2010. Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: An essential component of disease management. Eur Respir Rev 19:314-320.
14. Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y. 2011. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 70:2029-2036.
15. Hu X, Ivashkiv LB. 2009. Cross-regulation of signaling pathways by interferon-gamma: Implications for immune responses and autoimmune diseases. Immunity 31:539-550.
16. Kahaleh B. 2008. Vascular disease in scleroderma: Mechanisms of vascular injury. Rheum Dis Clin North Am 34:57-71; vi.
17. Kalra S, Utz JP, Ryu JH. 2003. Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis. Mayo Clin Proc 78:1082-1087.
18. Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, Silver RM, Jablonska S, Blaszczyk M, Watson DK, Trojanowska M. 2003. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 163:571-581.
19. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T. 1990. Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 86:917-922.
20. Laato M, Heino J, Gerdin B, Kahari VM, Niinikoski J. 2001. Interferon-gamma-induced inhibition of wound healing in vivo and in vitro. Ann Chir Gynaecol 215:19-23.
21. Lafyatis R, York M. 2009. Innate immunity and inflammation in systemic sclerosis. Curr Opin Rheumatol 21:617-622.
22. Lamas S, Michel T, Collins T, Brenner BM, Marsden PA. 1992. Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J Clin Invest 90:879-887.
23. Li Z, Jimenez SA. 2011. Protein kinase Cdelta and c-Abl kinase are required for transforming growth factor beta induction of endothelial-mesenchymal transition in vitro. Arthritis Rheum 63:2473-2483.
24. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. 2010. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16:1400-1406.
25. Minagar A, Long A, Ma T, Jackson TH, Kelley RE, Ostanin DV, Sasaki M, Warren AC, Jawahar A, Cappell B, Alexander JS. 2003. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10:299-307.
26. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M. 2006. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 281:25259-25269.
27. Pattanaik D, Brown M, Postlethwaite AE. 2011. Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 4:105-125.
28. Piera-Velazquez S, Li Z, Jimenez SA. 2011. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179:1074-1080.
29. Rabquer BJ, Tsou PS, Hou Y, Thirunavukkarasu E, Haines GK III, Impens AJ, Phillips K, Kahaleh B, Seibold JR, Koch AE. 2011. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther 13:R18.
30. Richard L, Velasco P, Detmar M. 1998. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp Cell Res 240:1-6.
31. Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C. 2011. Inflammation-induced endothelial-to-mesenchymal transition: A novel mechanism of intestinal fibrosis. Am J Pathol 179:2660-2673.
32. Schoenborn JR, Wilson CB. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41-101.
33. Schrijver HM, Hooper-van Veen T, van Belzen MJ, Crusius JB, Pena AS, Barkhof F, Polman CH, Uitdehaag BM. 2004. Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis. Eur J Immunogenet 31:133-140.
34. Segel MJ, Izbicki G, Cohen PY, Or R, Christensen TG, Wallach-Dayan SB, Breuer R. 2003. Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis. Am J Physiol Lung Cell Mol Physiol 285:L1255-L1262.
35. Steen V, Denton CP, Pope JE, Matucci-Cerinic M. 2009. Digital ulcers: Overt vascular disease in systemic sclerosis. Rheumatology (Oxford) 48:iii19-iii24.
36. Sugimura R, Li L. 2010. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today 90:243-256.
37. Sulli A, Soldano S, Pizzorni C, Montagna P, Secchi ME, Villaggio B, Seriolo B, Brizzolara R, Cutolo M. 2009. Raynaud's phenomenon and plasma endothelin: Correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 36:1235-1239.
38. Taniguchi T, Asano Y, Hatano M, Tamaki Z, Tomita M, Kawashima T, Miyazaki M, Sumida H, Akamata K, Takahashi T, Ichimura Y, Toyama T, Sugita M, Noda S, Yao A, Kinugawa K, Sato S. 2012. Effects of bosentan on nondigital ulcers in patients with systemic sclerosis. Br J Dermatol 166:417-421.
39. Tellides G, Pober JS. 2007. Interferon-gamma axis in graft arteriosclerosis. Circ Res 100:622-632.
40. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS. 2000. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403:207-211.
41. Trojanowska M. 2010. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol 6:453-460.
42. Varga J, Olsen A, Herhal J, Constantine G, Rosenbloom J, Jimenez SA. 1990. Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. Eur J Clin Invest 20:487-493.
43. Wastowski IJ, Sampaio-Barros PD, Martelli-Palomino G, Marques-Neto JF, Crispim JC, Rassi DM, Donadi EA. 2009. Association of Interferon-gamma gene polymorphism (+874 T/A) with systemic sclerosis. Dis Markers 27:93-95.
44. Widyantoro B, Emoto N, Nakayama K, Anggrahini DW, Adiarto S, Iwasa N, Yagi K, Miyagawa K, Rikitake Y, Suzuki T, Kisanuki YY, Yanagisawa M, Hirata K. 2010. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 121:2407-2418.
45. Yin Q, Nan HY, Zhang WH, Yan LF, Cui GB, Huang XF, Wei JG. 2011. Pulmonary microvascular endothelial cells from bleomycin-induced rats promote the transformation and collagen synthesis of fibroblasts. J Cell Physiol 226:2091-2102.
46. Zohlnhofer D, Richter T, Neumann F, Nuhrenberg T, Wessely R, Brandl R, Murr A, Klein CA, Baeuerle PA. 2001. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell 7:1059-1069.